Etoposide data

OIA response

Request dated 10 December 2018 for information relating to etoposide.

29 January 2019

[Name and contact details redacted]

Dear [Name redacted]


Thank you for your request for information dated 10 December 2018 under the Official Information Act 1982 (OIA) for information relating to etoposide. 

You requested usage data for the following four products:

  • Etoposide Cap 50mg  
  • Etoposide Cap 100mg
  • Etopophos Etoposide Phosphate Inj 100mg
  • Etoposide Inj 20mg

Unit usage data on:

  1. Period of 2 years (by month)
  2. DHBs who have used these products
  3. Units used by each DHB
  4. Departments in DHB who have used the products by unit volume (show year volumes no need to break down into by month)

The information you requested in respect of points 1 – 3 above is attached. [XLSX, 143 KB]

In respect of point 4 above, we do not hold data for departments in DHBs and this aspect of your request is therefore refused under section 18 (g) of the OIA, as the information is not held by PHARMAC, and we have no reason to believe it is held by another agency in that form.

Please note you have the right, by way of complaint under section 28(3) of the OIA to an Ombudsman, to seek an investigation and review of our decision.

We trust that the provision of this information answers your queries, if you have any further questions please feel free to contact us again.

Yours sincerely

[Alison Hill's signature]

Alison Hill
Director, Engagement and Implementation